Chemoprotection by VEGF: Rationale for combination nab-paclitaxel and bevacizumab

被引：0
|
作者：
Trieu, V.
Ran, S.
Bivens, C.
Desai, N.
机构：
[1] Abraxis BioSci Inc, Los Angeles, CA USA
[2] Southern Illinois Univ, Sch Med, Springfield, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1064
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Gemcitabine nab-paclitaxel combination with DMAPT in PDAC cachexia
    Counts, Brittany
    Jean, Sephora
    Wang, Reggie
    Zimmers, Teresa
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Combination of nab-Paclitaxel and Bevacizumab Inhibited Tumor Growth and Metastasis of New Inflammatory Breast Cancer Models
    Volk, L. D.
    Wilber, A.
    Trieu, V.
    Desai, N.
    Ran, S.
    CANCER RESEARCH, 2010, 70
  • [3] Synergistic effect of nab-paclitaxel and anti-VEGF-A antibody (bevacizumab) against the metastasis of breast tumor xenografts
    Ran, S.
    Bivens, C.
    Trieu, V.
    Desai, N.
    EJC SUPPLEMENTS, 2006, 4 (12): : 37 - 37
  • [4] Reminder that paclitaxel and nab-paclitaxel not interchangeable
    Reactions Weekly, 2022, 1894 (1) : 2 - 2
  • [5] A phase I/II trial of combination nab-paclitaxel and nintedanib or nab-paclitaxel and placebo in relapsed NSCLC adenocarcinoma (N3)
    Tokaca, N.
    Espinasse, A.
    Petruckevitch, A.
    Ellis, S.
    Yousaf, N.
    Bhosle, J.
    O'Brien, M.
    Popat, S.
    LUNG CANCER, 2017, 103 : S77 - S78
  • [6] Combination of nab-Paclitaxel and Bevacizumab Inhibited Tumor Growth and Metastasis of a New Triple Negative Breast Cancer Model
    Ran, S.
    Trieu, V.
    Volk, L. D.
    Wilber, A.
    Desai, N.
    CANCER RESEARCH, 2010, 70
  • [7] nab-Paclitaxel in Combination with Carboplatin for a Previously Treated Thymic Carcinoma
    Makimoto, Go
    Fujiwara, Keiichi
    Watanabe, Hiromi
    Kameyama, Nobuhisa
    Matsushita, Mizuho
    Rai, Kammei
    Sato, Ken
    Yonei, Toshiro
    Sato, Toshio
    Shibayama, Takuo
    CASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 14 - 17
  • [8] Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in advanced cancers.
    Sen, Shiraj
    Piha-Paul, Sarina Anne
    Kato, Shumei
    Karp, Daniel D.
    Janku, Filip
    Fu, Siqing
    Naing, Aung
    Pant, Shubham
    Tsimberidou, Apostolia Maria
    Subbiah, Vivek
    Kurzrock, Razelle
    Meric-Bernstam, Funda
    Hong, David S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Mechanisms of nab-paclitaxel and anti-VEGF combination therapy in the inhibition of breast tumor survival and inflammatory response
    Volk, Lisa
    Stutzman, Alan
    Flister, Michael
    Hall, Kelly
    Chihade, Deena
    Desai, Neil
    Trieu, Vuong
    Ran, Sophia
    CANCER RESEARCH, 2009, 69
  • [10] Mechanisms of nab-paclitaxel and bevacizumab cooperation in inhibition of breast tumor growth and metastasis
    Volk, L.
    Stutzman, A.
    Flister, M.
    Hall, K.
    Chihade, D.
    Desai, N.
    Trieu, V
    Ran, S.
    CANCER RESEARCH, 2009, 69 (02) : 115S - 115S
12345